Passivo Circulante Alterar Data
Abbott USD 18.38B 1.88B 2026-03
Accuray USD 199.44M 4.83M 2025-12
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 92.7M 8.86M 2026-03
AtriCure USD 81.92M 8.72M 2026-06
Boston Scientific USD 6.43B 1.86B 2026-06
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Inogen USD 64.94M 2.12M 2025-09
Mesa Laboratories USD 54.4M 6.1M 2025-12
Orthofix International USD 161.03M 9.45M 2026-03
Tandem Diabetes Care USD 247.96M 5.24M 2026-03
Trinity Biotech USD 141.21M 106.72M 2025-12